Investing.com - Merck&Co reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck&Co announced earnings per share of $1.75 on revenue of $13.15B. Analysts polled by Investing.com anticipated EPS of $1.54 on revenue of $12.26B.
Merck&Co shares are up 7% from the beginning of the year and are trading at $81.54 , down-from-52-week-high.They are under-performing the Dow Jones which is up 15.96% from the start of the year.
Merck&Co follows other major Healthcare sector earnings this month
Merck&Co's report follows an earnings beat by Hoya Corp on Thursday, who reported EPS of $1.02 on revenue of $1.43B, compared to forecasts EPS of $0.9772 on revenue of $1.42B.
Iqvia had beat expectations on Thursday, October 21, 2021 with third quarter EPS of $2.17 on revenue of $3.39B, compared to forecast for EPS of $2.12 on revenue of $3.35B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar